We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CRS:NYSECarpenter Technology Corporation Analysis

Data as of 2026-03-27 - not real-time

$391.62

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Carpenter Technology (CRS) is trading at $391.62, comfortably above its 20‑day ($390.04) and 50‑day ($368.57) SMAs, indicating a bullish price trend, while the 14‑day RSI sits at 53, suggesting neutral momentum. The MACD histogram is negative and the MACD line sits below its signal, flagging a short‑term bearish tilt even as the broader trend remains bullish. Volatility is elevated at nearly 49% over the past 30 days and beta is high at 1.43, underscoring sensitivity to market swings. Valuation metrics are stretched: a trailing P/E of 45.4 far exceeds the industry average of 28.5, and the DCF‑derived fair value of $84.87 implies the stock is priced about 5% above intrinsic estimates. Revenue grew 7.5% year‑over‑year with strong operating margins (21%) and a healthy ROE of 23%, while the dividend yield is modest at 0.2% with a low payout ratio of 9%. Recent earnings showed a 31% jump in operating income, and the company enjoys strong analyst sentiment (strong‑buy) and inclusion in billionaire Stanley Druckenmiller’s top‑10 picks. Support sits at $351.20 and resistance at $412.31, with volume trending upward, suggesting the stock could test the upside ceiling while remaining vulnerable to a pullback if bearish technical signals sharpen.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above key moving averages but MACD turning bearish
  • Approaching resistance near $412 with limited upside
  • High short‑term volatility and beta

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Robust 7.5% revenue growth and 21% operating margin
  • Strong earnings beat and analyst strong‑buy consensus
  • Expanding aerospace and defense demand for specialty alloys

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Durable niche in high‑performance metals with solid ROE
  • Valuation premium relative to peers and DCF gap
  • Sustained cash flow generation despite high beta and volatility

Key Metrics & Analysis

Financial Health

Revenue Growth7.50%
Profit Margin14.77%
P/E Ratio45.4
ROE23.49%
ROA10.75%
Debt/Equity35.19
P/B Ratio9.8
Op. Cash Flow$503.7M
Free Cash Flow$253.1M
Industry P/E28.5

Technical Analysis

TrendBullish
RSI53.1
Support$351.20
Resistance$412.31
MA 20$390.04
MA 50$368.57
MA 200$301.52
MACDBearish
VolumeIncreasing
Fear & Greed Index72.43

Valuation

Fair Value$84.87
Target Price$412.75
Upside/Downside5.40%
GradeOvervalued
TypeGrowth
Dividend Yield0.20%

Risk Assessment

Beta1.43
Volatility48.77%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.